Prazitone

Prazitone

Clinical data
Other names	5-phenyl-5-(2-piperidylmethyl)barbituric acid
ATC code	none
Identifiers
IUPAC name 5-phenyl-5-(piperidin-2-ylmethyl)pyrimidine-2,4,6(1H,3H,5H)-trione
CAS Number	2409-26-9 Y
PubChem CID	3050417
ChemSpider	2312482 N
UNII	6DZB018428
Chemical and physical data
Formula	C16H19N3O3
Molar mass	301.346 g·mol−1
3D model (JSmol)	Interactive image
SMILES C1CCNC(C1)CC2(C(=O)NC(=O)NC2=O)C3=CC=CC=C3
InChI InChI=1S/C16H19N3O3/c20-13-16(11-6-2-1-3-7-11,14(21)19-15(22)18-13)10-12-8-4-5-9-17-12/h1-3,6-7,12,17H,4-5,8-10H2,(H2,18,19,20,21,22) N Key:UGZAKKMLMJITLL-UHFFFAOYSA-N N
NY (what is this?)  (verify)

Prazitone (AGN-511) is a barbiturate derivative developed in the 1970s.^[1] Unlike most barbiturates, it has little or no sedative effects, instead acting as a non-sedating anxiolytic and antidepressant.^[2] The dosage range in humans is around 200–600 mg, although higher doses have been used in trials for the treatment of depression associated with Parkinson's disease.

References

This article about an anxiolytic is a stub. You can help Wikipedia by expanding it.

• v
• t
• e

This page was last edited on 26 January 2023, at 11:26